Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.24 USD | +4.33% |
|
+7.69% | +13.68% |
07-01 | Travere Therapeutics, Inc.(NasdaqGM:TVTX) dropped from Russell 3000 Growth Index | CI |
07-01 | Travere Therapeutics, Inc.(NasdaqGM:TVTX) dropped from Russell 3000E Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.68% | 747M | |
+20.40% | 127B | |
+24.40% | 117B | |
+25.44% | 27.67B | |
-18.48% | 20.33B | |
-15.17% | 16.79B | |
-16.28% | 15.63B | |
+13.13% | 14.84B | |
-47.10% | 14.65B | |
+56.66% | 14.43B |
- Stock Market
- Equities
- TVTX Stock
- News Travere Therapeutics, Inc.
- Retrophin, Inc. Provides Preliminary and Unaudited Financial Data for the Fourth Quarter and Full Year of 2016